0

COLAZAL از شرکت VALEANT PHARMS INTL

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

COLAZAL از شرکت VALEANT PHARMS INTL

New Drug Application (NDA): 020610

Company: VALEANT PHARMS INTL

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
COLAZAL BALSALAZIDE DISODIUM 750MG CAPSULE;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
07/18/2000 ORIG-1 Approval

Type 1 – New Molecular Entity

STANDARD

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20610lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/20610ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-610_Colazal.cfm

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/01/2020 SUPPL-23 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020610s023lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/020610Orig1s023ltr.pdf

06/21/2019 SUPPL-21 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020610s021lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/020610Orig1s021ltredt.pdf

01/05/2015 SUPPL-20 Manufacturing (CMC)

Label is not available on this site.

03/05/2014 SUPPL-19 Manufacturing (CMC)

Label is not available on this site.

07/09/2008 SUPPL-18 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020610s018ltr.pdf

11/02/2007 SUPPL-17 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020610s017lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/020610s017ltr.pdf

12/20/2006 SUPPL-16 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s016lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s016ltr.pdf

09/21/2006 SUPPL-14 Labeling

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s014lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s014ltr.pdf

03/10/2006 SUPPL-13 Manufacturing (CMC)-Packaging

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/020610s013ltr.pdf

02/07/2002 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

06/18/2002 SUPPL-1 Labeling

Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20610s001ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
10/01/2020 SUPPL-23

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/020610s023lbl.pdf
06/21/2019 SUPPL-21

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020610s021lbl.pdf
11/02/2007 SUPPL-17

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020610s017lbl.pdf
12/20/2006 SUPPL-16

Efficacy-New Patient Population

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s016lbl.pdf
09/21/2006 SUPPL-14

Labeling

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/020610s014lbl.pdf
07/18/2000 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20610lbl.pdf

COLAZAL

CAPSULE;ORAL; 750MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
BALSALAZIDE DISODIUM BALSALAZIDE DISODIUM 750MG CAPSULE;ORAL Prescription No AB 077883 APOTEX INC
BALSALAZIDE DISODIUM BALSALAZIDE DISODIUM 750MG CAPSULE;ORAL Prescription No AB 077806 HIKMA
COLAZAL BALSALAZIDE DISODIUM 750MG CAPSULE;ORAL Prescription Yes AB 020610 VALEANT PHARMS INTL
بخوانید  CARVEDILOL از شرکت BEXIMCO USA
برچسب‌ها:

نظرات کاربران